DOI: 10.1016/j.atherosclerosis.2016.04.017 Influences on plasminogen activator inhibitor-2 polymorphism-associated recurrent cardiovascular disease risk in patients with high HDL cholesterol and inflammation James P. Corsetti, Peter Salzman, Dan Ryan, Arthur J. Moss, Wojciech Zareba, Charles E. Sparks Atherosclerosis Volume 250, Pages 1-8 (July 2016) DOI: 10.1016/j.atherosclerosis.2016.04.017 Copyright © 2016 Elsevier Ireland Ltd Terms and Conditions
Fig. 1 Subgraphs of Bayesian networks delineating direct forebears of outcome up to the grandparent level for (A) BN1, (B) BN2, and (C) BN3. Genetic polymorphism variables are indicated by an asterisk (multiple asterisks indicate position of the polymorphism in Table 2). Atherosclerosis 2016 250, 1-8DOI: (10.1016/j.atherosclerosis.2016.04.017) Copyright © 2016 Elsevier Ireland Ltd Terms and Conditions